Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
17.72x2.32x5.05x4.09x9.62x11.23x0.51% 75.96B
22.79x3.55x1.17x4.95x14.39x17.77x0.65% 49.03B
35.94x7.39x0.66x12.28x23.37x27.35x-.--% 47.88B
-58.2x2.68x0.46x3.39x10.02x11.68x3.15% 43.39B
37.93x1.7x-1.01x3.44x12.89x14.62x-.--% 30.8B
53.82x4.12x-0.83x3.4x26.33x23.45x-.--% 24.45B
-6.64x4.03x-0.37x9.07x-5.85x-5.46x-.--% 22.75B
64.19x5.58x0.44x6.07x41.78x48.25x-.--% 19.24B
-36.55x-6.54x0.9x17.57x-48.07x-55.04x-.--% 16.04B
22.86x3.36x0.02x4.93x12.83x17.83x-.--% 15.87B
63.49x25.89x0.6x50.48x71.4x73.63x0.15% 13.02B
17.98x - 0.21x3.68x14.22x16.61x-.--% 11.74B
-102.17x11237.82x2.35x11.04x-79.04x-109.09x-.--% 10.92B
43.35x - 4.55x - - - -.--% 9.61B
12.99x1.21x0.39x1.91x7.66x10.43x2.7% 7.03B
-60.07x - -2.2x - - - - 6.24B
30.13x - 1.48x8.14x21.59x25.78x0.34% 6.17B
60.21x7.23x0.88x5.86x32.4x43.64x-.--% 5.93B
-115.99x - 7.68x - - - -.--% 5.72B
Average 5.46x 807.17x 1.18x 9.39x 10.35x 10.79x 0.42% 22.2B
Weighted average by Cap. 11.71x 324.88x 1.38x 7.70x 11.86x 13.05x 0.55%
Biopharmaceuticals